Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.
July 14, 2015•8 min
JAMA Editors' Summary: On research in medicine, science, & clinical
practice. For physicians, researchers, & clinicians.
Chat About Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.